McClain KL - Search Results

1

BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor.

Mastropolo R, Close A, Allen SW, McClain KL, Maurer S, Picarsic J. Mastropolo R, et al. Among authors: mcclain kl. Blood Adv. 2019 Jun 25;3(12):1848-1853. doi: 10.1182/bloodadvances.2019000093. Blood Adv. 2019. PMID: 31213430 Free PMC article.

2

Expression profiling using human tissues in combination with RNA amplification and microarray analysis: assessment of Langerhans cell histiocytosis.

McClain KL, Cai YH, Hicks J, Peterson LE, Yan XT, Che S, Ginsberg SD. McClain KL, et al. Amino Acids. 2005 May;28(3):279-90. doi: 10.1007/s00726-005-0177-x. Epub 2005 Mar 30. Amino Acids. 2005. PMID: 15791395 Review.

3

A phase II trial using thalidomide for Langerhans cell histiocytosis.

McClain KL, Kozinetz CA. McClain KL, et al. Pediatr Blood Cancer. 2007 Jan;48(1):44-9. doi: 10.1002/pbc.20578. Pediatr Blood Cancer. 2007. PMID: 16333818 Clinical Trial.

4

Langerhans cell histiocytosis: a review of past, current and future therapies.

Allen CE, McClain KL. Allen CE, et al. Among authors: mcclain kl. Drugs Today (Barc). 2007 Sep;43(9):627-43. doi: 10.1358/dot.2007.43.9.1088823. Drugs Today (Barc). 2007. PMID: 17940639 Review.

5

Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis.

Phillips M, Allen C, Gerson P, McClain K. Phillips M, et al. Pediatr Blood Cancer. 2009 Jan;52(1):97-101. doi: 10.1002/pbc.21782. Pediatr Blood Cancer. 2009. PMID: 18951435

6

Diabetes insipidus in Langerhans cell histiocytosis: When is treatment indicated?

Abla O, Weitzman S, Minkov M, McClain KL, Visser J, Filipovich A, Grois N. Abla O, et al. Among authors: mcclain kl. Pediatr Blood Cancer. 2009 May;52(5):555-6. doi: 10.1002/pbc.21924. Pediatr Blood Cancer. 2009. PMID: 19142995 No abstract available.

7

Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside.

Allen CE, Flores R, Rauch R, Dauser R, Murray JC, Puccetti D, Hsu DA, Sondel P, Hetherington M, Goldman S, McClain KL. Allen CE, et al. Among authors: mcclain kl. Pediatr Blood Cancer. 2010 Mar;54(3):416-23. doi: 10.1002/pbc.22326. Pediatr Blood Cancer. 2010. PMID: 19908293 Free PMC article.

8

Optimal therapy for adults with Langerhans cell histiocytosis bone lesions.

Cantu MA, Lupo PJ, Bilgi M, Hicks MJ, Allen CE, McClain KL. Cantu MA, et al. Among authors: mcclain kl. PLoS One. 2012;7(8):e43257. doi: 10.1371/journal.pone.0043257. Epub 2012 Aug 15. PLoS One. 2012. PMID: 22916233 Free PMC article.

9

Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.

Gadner H, Minkov M, Grois N, Pötschger U, Thiem E, Aricò M, Astigarraga I, Braier J, Donadieu J, Henter JI, Janka-Schaub G, McClain KL, Weitzman S, Windebank K, Ladisch S; Histiocyte Society. Gadner H, et al. Among authors: mcclain kl. Blood. 2013 Jun 20;121(25):5006-14. doi: 10.1182/blood-2012-09-455774. Epub 2013 Apr 15. Blood. 2013. PMID: 23589673 Free article. Clinical Trial.

10

Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.

Simko SJ, Tran HD, Jones J, Bilgi M, Beaupin LK, Coulter D, Garrington T, McCavit TL, Moore C, Rivera-Ortegón F, Shaffer L, Stork L, Turcotte L, Welsh EC, Hicks MJ, McClain KL, Allen CE. Simko SJ, et al. Among authors: mcclain kl. Pediatr Blood Cancer. 2014 Mar;61(3):479-87. doi: 10.1002/pbc.24772. Epub 2013 Sep 18. Pediatr Blood Cancer. 2014. PMID: 24106153 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page